Biologicals: A Perspective for the Treatment of PMR/GCA
- 8 July 2017
- book chapter
- Published by Springer Nature
- p. 113-119
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- 2015 Recommendations for the Management of Polymyalgia Rheumatica: A European League Against Rheumatism/American College of Rheumatology Collaborative InitiativeArthritis & Rheumatology, 2015
- BSR and BHPR guidelines for the management of polymyalgia rheumaticaRheumatology, 2009
- Adjunctive methotrexate for treatment of giant cell arteritis: An individual patient data meta‐analysisArthritis & Rheumatism, 2007
- The polymyalgia rheumatica activity score in daily use: Proposal for a definition of remissionArthritis Care & Research, 2007
- Diagnosis, Differential Diagnosis and Treatment of Polymyalgia RheumaticaDrugs & Aging, 2006
- Polymyalgia Rheumatica and Giant-Cell ArteritisNew England Journal of Medicine, 2002
- Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumaticaArthritis & Rheumatism, 1997
- GIANT CELL ARTERITIS AND POLYMYALGIA RHEUMATICAMedical Clinics of North America, 1997
- Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double-blind study.Annals of the Rheumatic Diseases, 1986
- An evaluation of criteria for polymyalgia rheumatica.Annals of the Rheumatic Diseases, 1979